;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Aptose Biosciences, Oregon Health & Science University, LLS cancer news

    Aptose Biosciences Inc. (TSX:APS; Pink:APSCF), Toronto, Ontario Oregon Health & Science University, Portland, Ore. The Leukemia & Lymphoma Society, White Plains, N.Y. Business: Cancer Aptose (formerly Lorus Therapeutics…

    Published on 10/20/2014
  • Coronado Biosciences dermatology news

    Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass. Business: Dermatology Coronado formed Journey Medical Corp., a wholly owned subsidiary to acquire and license dermatology products for commercialization. The …

    Published on 10/20/2014
  • DecImmune Therapeutics, NIH cardiovascular news

    DecImmune Therapeutics Inc., Boston, Mass. National Institutes of Health, Bethesda, Md. Business: Cardiovascular DecImmune said NIH awarded the biotech a Phase IIB Small Business Innovation Research (SBIR) contract for…

    Published on 10/20/2014
  • Emergent BioSolutions, U.S. Department of Health and Human Services, NIH infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. National Institutes of Health, Bethesda, Md. Business: Infectious NIH's National Institute of Allergy…

    Published on 10/20/2014
  • NeuroSearch neurology news

    NeuroSearch A/S (CSE:NEUR), Ballerup, Denmark Business: Neurology NeuroSearch appealed to the Eastern High Court of Denmark an August ruling from the City Court of Copenhagen ordering the company to pay a fine of DKK5 …

    Published on 10/20/2014
  • Bill & Melinda Gates Foundation, Critical Path Institute infectious news

    Bill & Melinda Gates Foundation, Seattle, Wash. Critical Path Institute, Tucson, Ariz. Business: Infectious The institute received a three-year, multi-million dollar grant renewal from the foundation to support …

    Published on 10/13/2014
  • Bioheart gene/cell therapy news

    Bioheart Inc. (OTCQB:BHRT), Sunrise, Fla. Business: Gene/Cell therapy Last month, Bioheart opened its South African Stem Cell Institute (SASCI) laboratory and clinic in South Africa. At least 12 patients underwent …

    Published on 10/13/2014
  • BioMarin endocrine/metabolic news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Business: Endocrine/Metabolic BioMarin said an undisclosed company submitted an ANDA to FDA for a generic version of the biotech's Kuvan sapropterin …

    Published on 10/13/2014
  • Cellerant, U.S. Department of Health and Human Services cancer, other news

    Cellerant Therapeutics Inc., San Carlos, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Cancer, Other HHS's Biomedical Advanced Research and Development Authority (BARDA) exercised its …

    Published on 10/13/2014
  • Critical Outcome Technologies cancer news

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer Critical Outcome's board approved a shareholder rights plan to protect shareholders in the event of an unsolicited takeover …

    Published on 10/13/2014
  • Emmes Corp., NIH cancer news

    Emmes Corp., Rockville, Md. National Institutes of Health, Bethesda, Md. Business: Cancer CRO Emmes said clinical investigators from the AIDS Malignancy Consortium (AMC) began a study to investigate strategies to …

    Published on 10/13/2014
  • GenoSpace, NIH bioinformatics news

    GenoSpace LLC, Cambridge, Mass. National Institutes of Health, Bethesda, Md. Business:Bioinformatics GenoSpace said NIH awarded the biotech a Small Business Innovation Research (SBIR) grant for about $137,000 over about…

    Published on 10/13/2014
  • Hospira, Orion, Novartis neurology news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Orion Corp. (HSE:ORNAV; HSE:ORNBV), Espoo, Finland Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Neurology Orion, Hospira and Novartis' Sandoz Inc. and Sandoz …

    Published on 10/13/2014
  • Innovation Economy Corp. other news

    Innovation Economy Corp., Riverside, Calif. Business: Other Innovation Economy (dba ieCrowd) launched a life science business group and appointed Molly Schmid as VP of the group. ieCrowd, a discovery-to-market …

    Published on 10/13/2014
  • Kymab, Regeneron antibodies news

    Kymab Ltd., Cambridge, U.K. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Business: Antibodies Kymab said the European Patent Office (EPO) has granted Kymab's request to entirely revoke Regeneron's EP1,…

    Published on 10/13/2014
  • MediciNova, NIH neurology news

    MediciNova Inc. (NASDAQ:MNOV; JASDAQ:4875), San Diego, Calif. National Institutes of Health, Bethesda, Md. Business: Neurology MediciNova said NIH's National Institute on Drug Abuse (NIDA) awarded a grant to continue …

    Published on 10/13/2014
  • Mimetas, National Center for the Replacement, Radboud University Nijmegen Medical Center, University of Applied Sciences and Arts Northwestern Switzerland supply/service news

    Mimetas B.V., Leiden, the Netherlands National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, U.K. Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands …

    Published on 10/13/2014
  • Navidea, NIH diagnostic news

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio National Institutes of Health, Bethesda, Md. Business: Diagnostic Navidea said NIH's NCI awarded the biotech a Small Business Innovation Research (SBIR) …

    Published on 10/13/2014
  • Novo Nordisk endocrine/metabolic news

    Novo Nordisk A/S (CSE:NVO; NYSE:NVO), Bagsvaerd, Denmark Business: Endocrine/Metabolic Novo Nordisk said it will establish a new obesity research unit in Seattle. The unit's main task will be to identify new approaches …

    Published on 10/13/2014
  • Agilent supply/service, diagnostic news

    Agilent Technologies Inc. (NYSE:A), Santa Clara, Calif. Business: Supply/Service, Diagnostic Agilent said its board approved the separation of the company's Keysight Technologies Inc. electronic measurement subsidiary …

    Published on 10/6/2014
  • Auxilium endocrine/metabolic, genitourinary, musculoskeletal news

    Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL), Chesterbrook, Pa. Business: Endocrine/Metabolic, Genitourinary, Musculoskeletal Auxilium will reduce headcount by about 30% to consolidate commercial operations and will …

    Published on 10/6/2014
  • BioCryst, NIH infectious news

    BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious BioCryst said NIH's National Institute of Allergy and Infectious Disease (NIAID) exercised two …

    Published on 10/6/2014
  • Caliber Biotherapeutics, Mapp Biopharmaceutical, U.S. Department of Health and Human Services infectious news

    Caliber Biotherapeutics LLC, Bryan, Texas Mapp Biopharmaceutical Inc., San Diego, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHS said it is in talks with biomanufacturing…

    Published on 10/6/2014
  • Chimerix, U.S. Department of Health and Human Services infectious news

    Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Chimerix said HHS's Biomedical Advanced Research and Development Authority (BARDA) extended …

    Published on 10/6/2014
  • Cytori gene/cell therapy, musculoskeletal news

    Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA), San Diego, Calif. Business: Gene/Cell therapy, Musculoskeletal Cytori will reduce headcount to about 77 from "a peak of 119 earlier this year" and will focus on its U.…

    Published on 10/6/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993